25 March 2013 -- The Regulatory Affairs Professionals Society (RAPS) will host a webcast, 27 March at 12:00 pm EDT, examining changes expected in the new EU in vitro diagnostics (IVDs) regulation.
Erik Vollebregt, partner with Amsterdam-based Axon Lawyers,will outline proposed changes and examine potential action items and how to implement them in regulated companies’ technical files and quality systems. Vollebregt specializes in EU legal and regulatory issues relating to medical devices.
Erik Vollebregt, partner, Axon Lawyers
90-minute webcast entitled The Proposal for a New EU In Vitro Diagnostics Regulation—Ins and Outs
27 March, 12:00–1:30 pm EDT
How to Access:
Members of the working media may request access to this live RAPS webcast or to the recording by contacting Zachary Brousseau, senior manager, communications, RAPS, at email@example.com or +1 301 770 2920, ext. 245.
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org